Search Results - "Conteduca, V"

Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.

Authors: Khani F Hooper WF Wang X et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2023 Nov 02; Vol. 7 (1), pp. 113. Date of Electronic Publication: 2023 Nov 02.

Publication Type: Published Erratum

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.

Authors: Conteduca V Ku SY Fernandez L et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2021 Sep 13; Vol. 5 (1), pp. 84. Date of Electronic Publication: 2021 Sep 13.

Publication Type: Published Erratum

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study.

Authors: Maffezzoli M Signori A Acunzo A et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Feb 03; Vol. 75 (3), pp. 66. Date of Electronic Publication: 2026 Feb 03.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study.

Authors: Bourlon MT Galli L Grande E et al.

Source: Frontiers in oncology [Front Oncol] 2025 Jul 25; Vol. 15, pp. 1605282. Date of Electronic Publication: 2025 Jul 25 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Association between proton pump inhibitor use and upper gastrointestinal cancer: A matched case-control study accounting for reverse causation and confounding by indication.

Authors: Sawaid, Ibrahim O. Din, Zohar Golan, Efrat et al.

Source: PLoS Medicine. 1/6/2026, Vol. 23 Issue 1, p1-16. 16p.

Association between lung cancer and prostate cancer: three studied cases and short literature review.

Alternate Title: Asocierea dintre cancerul pulmonar și cancerul de prostată: trei cazuri studiate şi scurtă analiză a literaturii de specialitate.

Authors: Grigorescu, Alexandru-Călin¹ alexgrigorescu2004@yahoo.com

Source: Oncolog-Hematolog. 2025, Issue 73, p22-25. 4p.

Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis.

Authors: Maiorano BA Roviello G Rizzo A et al.

Source: Scientific reports [Sci Rep] 2026 Jun 17. Date of Electronic Publication: 2026 Jun 17.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.

Authors: Kopp RM Massari F Grande E et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Nov 14; Vol. 74 (12), pp. 374. Date of Electronic Publication: 2025 Nov 14.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2^EV study.

Authors: Fiala O Buti S Fujita K et al.

Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2025 Feb 20; Vol. 42 (2), pp. 18. Date of Electronic Publication: 2025 Feb 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

This result is not displayed to guests.
Login for full access.

Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer?

Authors: Garofoli M Maiorano BA Bruno G et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Jun 16; Vol. 16, pp. 17588359241258443. Date of Electronic Publication: 2024 Jun 16 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

Authors: Turco F Gillessen S Salfi G et al.

Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2026 May 29. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

Lactate Dehydrogenase-5 and Tumor-Infiltrating Lymphocytes in Prostate Cancer Patients Undergoing Radical Hypofractionated Radiotherapy.

Authors: Koukourakis, Ioannis M. Platoni, Kalliopi Kouloulias, Vassilis et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2149. 16p.

Evaluation of a Methylated Circulating Tumour DNA Panel for Detection and Disease Stratification in Prostate Cancer.

Authors: Eriksen, Stine V. Zedan, Ahmed H. Kahns, Søren et al.

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p6081. 13p.

Diagnostic Efficacy of the International System for Reporting Serous Fluid Cytopathology Classification in Pleural Effusion Samples to Analyze the Risk of Malignancy Associated with Each Category and Explore the Prognostic Significance of the Systemic Immune-Inflammation Index within These Classifications

Authors: Singh, Gyanendra Patel, Tarang Danger, Avani et al.

Source: Journal of Cytology. Jul-Sep2026, Vol. 43 Issue 3, p167-173. 7p.

Inflammatory and Epigenetic Biomarkers in Prostate Disease: Current Evidence, Clinical Limitations, and Future Multimarker Strategies.

Authors: Donath-Miklos, Imola Popețiu, Romana Olivia Crișan, Adrian Silviu et al.

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 12, p1865. 26p.

Single-Cell Analysis Reveals Pre-Existing Basal-Associated Epithelial States in Metastatic Hormone-Naïve Prostate Cancer.

Authors: Watanabe, Ryuta Chosei, Mami Sakaue, Tomohisa et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5405. 14p.

¹⁷⁷Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.

Authors: Mandel P Groener D Follacchio G et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Oct 16; Vol. 229, pp. 115789. Date of Electronic Publication: 2025 Sep 12.

Publication Type: Journal Article; Multicenter Study; Comparative Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Exploratory case series of circulating tumor DNA dynamics during tandem therapy in metastatic castration-resistant prostate cancer.

Authors: Amghar, Mariam Rausch, Tobias Özgür, Hilal et al.

Source: EJNMMI Research. 2/11/2026, Vol. 16 Issue 1, p1-9. 9p.

Assessment of Meet-URO and CANLPH Prognostic Models in Metastatic RCC: Insights from a Single-Institution Cohort Predominantly Treated with TKIs.

Authors: Kuzu, Ömer Faruk Karadurmuş, Nuri Kanat, Nebi Batuhan et al.

Source: Diagnostics (2075-4418). Feb2026, Vol. 16 Issue 3, p428. 11p.